UMIN-CTR Clinical Trial

Unique ID issued by UMIN C000000398
Receipt number R000000487
Scientific Title Evaluation of nutrition, immunology and QOL of the patients with liver cirrhosis by administration of oral amino-acid agent and nutritional care
Date of disclosure of the study information 2012/04/01
Last modified on 2015/08/30 10:14:42

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of nutrition, immunology and QOL of the patients with liver cirrhosis by administration of oral amino-acid agent and nutritional care

Acronym

GLSG, 2006, nutrition

Scientific Title

Evaluation of nutrition, immunology and QOL of the patients with liver cirrhosis by administration of oral amino-acid agent and nutritional care

Scientific Title:Acronym

GLSG, 2006, nutrition

Region

Japan


Condition

Condition

Liver Cirrhosis

Classification by specialty

Medicine in general Hepato-biliary-pancreatic medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate nutrition, immunnity and QOL of the patients with liver cirrhosis by administration of oral amino-acid agent

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase IV


Assessment

Primary outcomes

cell immunity

Key secondary outcomes

morbidity
safety


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

aminolevan EN

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >=

Gender

Male and Female

Key inclusion criteria

Liver cirrhosis (child B)
the patients with insufficient elevation of serum albumin value by administration of BCAA granules

Key exclusion criteria

the patients with
regularly administration of albumin,
administration of other oral amino-acid agents,
renal dysfunction,
congenital amino-acid metabolic dysfunction,
cirrhosis by autoimmune mechanism,
scheduled treatment of varices within 3 months, with
uncontrollable ascites

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Ken Sato

Organization

Gunma University Graduate School of medicine

Division name

Department of Medicine and Molecular Science

Zip code


Address

3-39-15 Showa, Maebashi, Gunma 371-8511

TEL

027-220-8127

Email

satoken@gunma-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Ken Sato

Organization

Gunma University Graduate School of medicine

Division name

Department of Medicine and Molecular Science

Zip code


Address

3-39-15 Showa, Maebashi, Gunma 371-8511

TEL

027-220-8127

Homepage URL


Email

satoken@gunma-u.ac.jp


Sponsor or person

Institute

Gunma Liver Study Group (GLSG)

Institute

Department

Personal name



Funding Source

Organization

Gunma Liver Study Group (GLSG)

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2012 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2005 Year 07 Month 31 Day

Date of IRB


Anticipated trial start date

2005 Year 08 Month 01 Day

Last follow-up date

2012 Year 08 Month 01 Day

Date of closure to data entry

2012 Year 08 Month 01 Day

Date trial data considered complete

2013 Year 02 Month 01 Day

Date analysis concluded

2013 Year 02 Month 01 Day


Other

Other related information



Management information

Registered date

2006 Year 04 Month 05 Day

Last modified on

2015 Year 08 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000000487


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name